A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

NCT06680947 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: 610
DRUG: 610
DRUG: Placebo

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.